Obesity

Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review

Ann Intern MedPublished Systematic review of randomised controlled trials

An erratum to this article was published (Ann Intern Med, Jul 2026 ↗)

Authors' conclusion

Loss of muscle-related indices exceeded prespecified benchmarks in about two thirds of incretin-based interventions and in nearly half of nonpharmacologic interventions that produced weight loss.

Study context

Population
Adults (≥18 years) with obesity; mean age 20 to 63.7 years, mean BMI 27.9 to 41.6 kg/m²35 RCTs
Comparison
Incretin-based therapy vs placebo or lifestyle intervention
Outcome
Changes in fat mass, FFM, lean soft tissue, muscle-related indices and visceral adiposity by BIA, DXA, CT or MRI
Methodological detailsprespecified benchmarks, no meta-analysis (heterogeneous methods), 8102 titles and abstracts screened; median duration 26 weeks; median 78 participants, 42.9% at low risk of bias; 10 (28.6%) prespecified body composition as primary outcome
  • Prespecified benchmarks
  • No meta-analysis (heterogeneous methods)
  • 8102 titles and abstracts screened; median duration 26 weeks; median 78 participants
  • 42.9% at low risk of bias; 10 (28.6%) prespecified body composition as primary outcome

Pooled result

As reported in the abstract

Proportion of total weight loss attributable to reductions in muscle-based indices
GroupValueExceeding the benchmark of about 25%
Incretinmedian 28.3% (IQR 15.9%–39.9%)65%

Incretin

Valuemedian 28.3% (IQR 15.9%–39.9%)
Exceeding the benchmark of about 25%65%

Further pooled results

Muscle-based share of weight loss, bioelectrical impedance analysis (BIA) or DXA studies (incretin)
about 29% · median · IQR 16.6%–43.1%
Muscle-based share of weight loss, computed tomography (CT) or magnetic resonance imaging (MRI) studies (incretin)
about 25.3% · median · IQR 16.7%–27.2%
Weight loss in lifestyle or placebo comparators (13 studies)
−2.5% · median · IQR −4.5%–-0.9%

Original publication

Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review. Ann Intern Med. Published 17 April 2026. doi:10.7326/annals-25-00478

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.